Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Female × Letrozole × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 336 Polycystic Ovary Syndrome 37 Neoplasm Metastasis 21 Endometrial Neoplasms 21 Ovarian Neoplasms 16 Neoplasms 13 Infertility 9 Advanced Breast Cancer 9 Fallopian Tube Neoplasms 8 Recurrence 7 Carcinoma, Intraductal, Noninfiltrating 7 Carcinoma, Ductal, Breast 7 Osteoporosis 6 Carcinoma, Lobular 6 Breast Neoplasms, Male 6 Breast Diseases 6 Triple Negative Breast Neoplasms 5 Breast Carcinoma In Situ 5 Prostatic Neoplasms 4 Leiomyoma 4 Infertility, Female 4 Hereditary Sensory and Autonomic Neuropathies 4 Breast Cancer Metastatic 4 Arthralgia 4 Obesity 3 Neoplasms, Hormone-Dependent 3 Carcinoma, Ovarian Epithelial 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2

Interventions

Tamoxifen 4 Exercise 3 pyrotinib 2 abemaciclib 2 Paclitaxel 2 Metformin 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 Aromatase Inhibitors 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tumor Burden 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04584853 2026-01-14

POETIC-A

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡